BASIS OF PRESENTATION (Details Narrative) - USD ($) |
3 Months Ended | |||
|---|---|---|---|---|
Mar. 31, 2019 |
Jan. 18, 2019 |
Jan. 02, 2019 |
Sep. 30, 2018 |
|
| Ownership allocation after merger of Company's common stock | 8.90% | |||
| Common stock, issued | 2,829,248 | 56,466,428 | 2,829,248 | |
| Common stock, par value (in dollars per share) | $ 0.0001 | $ 0.0001 | ||
| NeuBaseTherapuetics, Inc. | Dr. Jason Slakter [Member] | ||||
| Retention bonus amount | $ 75,000 | |||
| Financing Agreements [Member] | NeuBase Therapeutics, Inc [Member] | ||||
| Gross proceeds | $ 9,000,000 | |||
| Discription of ownership hold | NeuBase Financings, current stockholders, option holders, warrant holders and note holders of NeuBase will own, or hold rights to acquire, approximately 85% of the fully-diluted common stock of Ohr, and Ohr’s current stockholders, option holders and warrant holders will own, or hold rights to acquire, approximately 15% of the fully-diluted common stock of the Company. | |||
| Termination fee of merger agreement to be paid | $ 250,000 | |||
| Ownership allocation after merger of Company's common stock | 76.12% |
| X | ||||||||||
- Definition The ownership interest in the merged entity after all transactions have been completed. No definition available.
|
| X | ||||||||||
- Definition The amount of retention bonus resulting from contractual terms due to merger agreement. No definition available.
|
| X | ||||||||||
- Definition The amount of termination fee that may be required to be paid to NeuBase or NeuBase pays the Company under merger agreement. No definition available.
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Description of noncontrolling interest which might include background information, terms of the ownership arrangement, and type and terms of equity interest owned by the noncontrolling interest holders. No definition available.
|
| X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|